October 13, 2014 12:24 PM EDT 0 comments

Runner and Multiple Myeloma Survivor Don Wright Completes 84th Marathon!

This past weekend, multiple myeloma survivor Don Wright completed the Ottawa Fall Colours Marathon – his 84th! Thanks to innovative cancer treatments, Don has been able to run marathons in all 50 states, spending precious time with his family and friends and raising awareness of the value of new cancer therapies.

Read More

October 7, 2014 11:23 AM EDT 0 comments

New Study Suggests Innovative Therapies Lower Total Cancer Care Costs

Not only do innovative cancer therapies save lives – they save money! A new study in the Journal of Oncology Practice suggests that new treatments lower overall cancer care costs by shortening hospital stays and reducing reliance on radiation therapy.

Read More

September 10, 2014 06:58 PM EDT 0 comments

Century Cures Initiative Convenes Congressional Roundtable to Discuss Accelerating the Pace of 21st Cures

Members of Congress were further alerted to many of the issues preventing efficient clinical trials and patient access to innovative medication during a roundtable discussion convened on Wednesday, September 10, 2014 by the House Committee on Energy and Commerce as part of the non-partisan 21st Century Cures initiative. While the conversation was not limited to cancer medication, the event raised several key points about the ongoing struggle to streamline the clinical trial process.

Read More

August 20, 2014 01:33 PM EDT 0 comments

New Wall Street Journal Editorial Calls the Demand to Reduce Drug Prices a “Medical Innovation Threat”

An editorial published yesterday in the Wall Street Journal argues that calls to reduce prices of new drugs is the latest threat to medical innovation. With pharmaceutical companies subject to a seemingly endless approval process and a narrow window of profitability before their patents lapse (resulting in affordable generic drugs which now account for 86% of total filled prescriptions), the piece claims that the ability to set their own prices is a key motivating force in driving medical innovation.

Read More

August 18, 2014 03:21 PM EDT 0 comments

Patient Advocacy Groups: Despite the Affordable Care Act, Insurers Still Working to Limit Patient Drug Access

A strongly worded letter to Health and Human Services Secretary Sylvia Mathews Burwell, signed by more than 300 patient advocacy groups, accuses insurance providers of employing discriminatory policies designed to limit patient access to certain essential drugs – despite the provisions outlined in the Affordable Care Act.

Read More